GlassScriptPhysician profile
Susanne Ginart
NPI 1598886012
$786.70
in general payments reported to CMS, 2019-2025
21 companies · $94.99 in 2025
The $94.99 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.91 · 2022: $111 · 2023: $246 · 2024: $239 · 2025: $94.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $98.57 | 2023-2024 | Briviact |
| Eisai INC. | $84.00 | 2021-2023 | |
| Corium, LLC | $57.47 | 2023-2024 | Azstarys |
| Neurelis, INC. | $51.55 | 2021-2023 | Valtoco |
| Tris Pharma INC | $46.82 | 2023-2024 | Dyanavel Xr, Onyda Xr |
| Abbvie INC. | $46.29 | 2021-2023 | |
| Immedica Pharma US, INC. | $45.79 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $44.92 | 2022-2025 | |
| Azurity Pharmaceuticals, INC. | $34.94 | 2024-2025 | Zonisade |
| Chiesi USA, INC. | $34.65 | 2021 | |
| Aquestive Therapeutics, INC. | $30.72 | 2024 | |
| Aprecia Pharmaceuticals, LLC | $28.64 | 2022-2023 | Spritam |
| Ns Pharma, INC. | $25.70 | 2023 | Viltepso |
| Medtronic, INC. | $24.89 | 2023 | Synchromedii |
| Takeda Pharmaceuticals U.S.A., INC. | $24.61 | 2025 | Vpriv |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $24.31 | 2024 | |
| Mimedx Group, INC. | $19.19 | 2025 | |
| Phadia US INC. | $17.00 | 2024 | Immunocap |
| Alexion Pharmaceuticals, INC. | $16.60 | 2024 | Koselugo |
| Teva Pharmaceuticals USA, INC. | $15.18 | 2025 | Ajovy |
| Supernus Pharmaceuticals, INC. | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanne Ginart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.